D-Tails Research

D-TAILS S.R.L. SB DISRUPTIVE TECHNOLOGICAL ADVANCES IN LIFE SCIENCE S.R.L. - SOCIETA' BENEFIT D-TAILS is dedicated to carryout research of disruptive technologies for early diagnosis of Alzheimer Disease and other neurodegenerative pathologies. New specific biocompatible marker are under development to detect Tau aggregates in the retina New specific mass screening test on urine are under development for breast cancer, prostate cancer and pancreatic cancer. C-elegans is a subject of study for the specific behavior when exposed to VOCs. Our imaging solutions include new super-resolution techniques, structured illumination, and adaptive optics.